A peripheral giant cell granuloma with extensive osseous metaplasia or a hybrid peripheral giant cell granuloma-peripheral ossifying fibroma: a case report by Ezinne I Ogbureke et al.
JOURNAL OF MEDICAL
CASE REPORTS
Ogbureke et al. Journal of Medical Case Reports 2015, 9:14
http://www.jmedicalcasereports.com/content/9/1/14CASE REPORT Open AccessA peripheral giant cell granuloma with extensive
osseous metaplasia or a hybrid peripheral giant
cell granuloma-peripheral ossifying fibroma:
a case report
Ezinne I Ogbureke1, Nadarajah Vigneswaran2, Matthew Seals1, Gary Frey1, Cleverick D Johnson1
and Kalu UE Ogbureke2*Abstract
Introduction: Peripheral giant cell granuloma and peripheral ossifying fibroma are clinicopathologically distinct
gingival lesions. Both are included in clinical differential diagnoses of common benign and reactive gingival
epulides in humans. It is often impossible to make a clinical distinction between the two entities, thereby making
definitive diagnosis dependent on histopathologic features. While our search of the English literature revealed
several reports of peripheral giant cell granuloma with ‘bone formation’, we were unable to identify any reports of
hybrid peripheral ossifying fibroma-peripheral giant cell granulomas.
Case presentation: We report a case of a 44-year-old Caucasian man presenting with a three-month history of
swelling of his right posterior mandible, related to an area of previous dental implant restoration. A clinical examination
revealed modest extraoral facial swelling of his right posterior mandible, while an intraoral examination showed a
45×25×15mm sessile, lobular soft tissue mass of the right posterior mandibular gingiva. The mucosal covering of the
lesion exhibited focal surface ulceration. A panoramic radiograph showed two implants at the vicinity of the lesion with
no other significant findings. An excisional biopsy of the lesion followed by histopathologic examination of the biopsy
specimen revealed salient and distinctive features of peripheral giant cell granuloma and of peripheral ossifying
fibroma, estimated at near equal proportions. This raises the possibility of a hybrid odontogenic lesion.
Conclusion: The presentation of this lesion, with areas of peripheral giant cell granuloma along with a distinct area of
extensive osseous formation and stroma reminiscent of a peripheral ossifying fibroma, justifies consideration of this as a
possible hybrid lesion. Although the biologic behavior of a combined lesion is not anticipated to deviate significantly
from that of either of the single entities, this case resurrects an enduring debate as to whether peripheral giant cell
granuloma and peripheral ossifying fibroma are simply parts of a disease spectrum, or whether some of these lesions
represent true hybrid lesions. It is therefore recommended that more cases with histopathologic features similar to the
lesion in our case be reported in the literature to further elucidate the histogenesis of these lesions.
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Figure 1 Clinical photograph of intraoral gingival soft tissue
swelling in the area of the right lower mandibular molar teeth.
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Peripheral ossifying fibroma (POsF) was first reported
and described by Shepherd as ‘alveolar exostosis’ in 1844
[1]. Because this lesion presents with a spectrum of his-
tomorphologic features, several subsequent reports have
characterized it variously as peripheral fibroma with
calcification, calcifying fibroblastic granuloma, ossifying
fibroid epulis, peripheral cemento-ossifying fibroma, and
calcifying fibroma [2,3]. The terminology has since stabi-
lized, with this entity now referred to as POsF, peripheral
cementifying fibroma, or peripheral cement-ossifying fi-
broma, depending on whether bone, cementum, or propor-
tions of each are present on microscopy [3-7]. Similarly,
peripheral giant cell granuloma (PGCG) was first reported
as fungus flesh in 1848 [4], then reported as giant cell rep-
arative granuloma by Jaffe in 1953 [8]. Subsequent reports
also featured a constellation of terminology such as osteo-
clastoma, giant cell epulis, and myeloid epulis [3]. PGCG
is now the preferred terminology.
POsF and PGCG are site-specific lesions arising exclu-
sively from the periodontal ligament. This makes both,
by definition, lesions of the gingiva or alveolar ridge
[9,10]. Their histogenesis is distinct from that of their re-
spective intraosseous (central) namesakes, central ossify-
ing fibroma (COF) and central giant cell granulomas
(CGCG), which are intra-bony benign neoplasms of the
jawbone [10]. Thus, POsF and PGCG are regarded as
reactive lesions of gingiva, often presenting as painless,
lobular, and ulcerated masses that are clinically indistin-
guishable from one another.
Cases of both POsF and of PGCG are occasionally
seen with isolated foci of the diagnostic histopathologic
feature of the other, but the preferred diagnosis of one
over the other is usually based on the predominant
morphologic features present in any specific case. Thus,
cases with predominantly stromal cells with numerous
osteoclast-like multinucleated giant cells with only focal
areas of calcified bone and/or cementum deposits are
diagnosed as PGCG. Those with a stroma comprising
aggregates of primitive oval and bipolar mesenchymal
cells, where a trabecular of woven and lamella bone with
cementum-like deposit often dominates, receive a POsF
diagnosis [11]. Archival papers by Dayan et al. [12] and
similar reports by Katsikeris et al. [13] highlighted the
overlaps in the histopathologic features of PGCG and
POsF. Here, we report on a case of PGCG with a distinct
region with an extensive osseous component and other
stromal features of POsF that may qualify this lesion as
a true case of hybrid PGCG-POsF. We also discuss the
pathogenesis of this lesion.
Case presentation
A 44-year-old Caucasian man presented to our Urgent
Care clinic with a complaint of swelling in his rightposterior mandibular molar teeth area that started about
three months previously. There was no associated pain
except for occasional interference of the swelling with
occlusion and mastication. His vital signs were within
normal ranges; his medical history included a family his-
tory of diabetes, cardiovascular disease, and cancers. His
previous dental treatment included two right posterior
quadrant dental implants, proximate to the lesion area,
placed three months prior to presentation.
On clinical examination, he had slight extraoral facial
swelling of his right posterior mandible, but his regional
lymph nodes were not palpable. An intraoral examin-
ation showed a 45×25×15mm sessile, lobular soft tissue
mass of his right posterior mandibular gingiva related to
his first and second premolars (Figure 1). The mucosal
covering of the lesion exhibited surface tan, red, and
bluish areas with a focal area of ulceration. A panoramic
radiograph of his jaws revealed two implants at his right
posterior mandible in the vicinity of the lesion (Figure 2)
with no other significant findings. These clinical and
radiographic findings indicated a benign lesion, and the
following differential diagnoses were generated: pyogenic
granuloma, POsF, peripheral odontogenic fibroma, focal
fibroepithelial hyperplasia, and PGCG. Malignant entities
such as squamous cell carcinoma, other primary malig-
nant lesions, and metastatic lesions, although thought to
be unlikely, were also considered. Complete excision of
the lesion was performed, and the entire specimen submit-
ted for histopathologic examination.
Microscopic examination of the hematoxylin and eosin-
stained sections of the specimen revealed a nodular soft
tissue specimen consisting of an ulcerated benign cellular
mesenchymal tissue proliferation supporting elaborate
trabecular bone formation, and occasional cementum-
like calcified deposits (Figure 3A,B,D). This interfaced
with stroma supporting aggregates of benign multinucle-
ated giant cells with hemorrhagic and hemosiderin
deposits (Figure 3A-3C). This framework was covered by
Figure 2 Panoramic radiograph of patient’s jaws. Shows no
evidence of intra-bony pathology in association with the soft tissue
lesion (arrow).
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epithelium maintaining the usual pattern of cellular mat-
uration, which rested on an intact basal cell layer with
elongated rete ridges. Where the surface epithelium was
discontinuous it was covered by a fibrinous layer support-
ing neutrophils and extravasated erythrocytes.
Discussion
Various combinations of so-called hybrid odontogenic
lesions have been reported [14]. These include reports of
several series on combined COF with CGCG [14-16].
For example, Allen et al. [15] reported three cases of
‘epithelium-rich’ COF, with ‘unusual associated giant cell
reaction’, whereas Tosios et al. [14] reported seven cases




Figure 3 Histopathologic micrograph of combined peripheral ossifyin
eosin-stained sections showing PGCG and POsF areas of lesion at (A) 10× ma
showing the PGCG area and prominent aggregates of multinucleated giant c
predominantly POsF area (arrow) within the hybrid lesion at 40× magnificationthe jaws. Odell et al. [16] gave a detailed microscopic de-
scription of eight patients with ‘hybrid central giant cell
granuloma and central odontogenic fibroma-like’ lesions.
There are also reports of CGCL with ameloblastoma,
and several non-odontogenic fibro-osseous lesions [17,18].
Although the case series reported by Dayan et al. [12] and
Katsikeris et al. [13] highlighted the formation of mineral-
ized tissues in PGCG, they did not find cementum-like
calcifications in the mineralized matrix in their respective
series. To the best of our knowledge, our case is the first
reported in which the PGCG area is distinct from the min-
eralized area and present in near equal proportion, and
the mineralized stroma contains occasional cementum-
like matrix.
POsFs are reactive lesions distinct from COFs, which
are true intraosseous neoplasms. Similarly, PGCGs are
reactive lesions that do not represent the intraosseous
counterpart of CGCG. In both pairings the peripheral
lesions present as indistinguishable histopathologic look-
alikes, as do the corresponding central lesions. Because
of the contiguity of the gingival and alveolar apparatus
to the alveolar bone, mandible, and maxilla, the presen-
tation of these entities occasionally raises the possibility
of either an intra-bony (mandible or maxilla) lesion that
eroded to the surface and into the overlying gingival soft
tissue, or an originally soft tissue lesion that burrowed
its way into bone [11]. In our case there was no radio-
graphic evidence of alveolar bone involvement, thereby
establishing the diagnosis of a soft tissue entity.
Dayan et al. [12] emphasized the absence of cemen-
tum deposits or matrix in PGCG with extensive osseousD
B
POsF
g fibroma and peripheral giant cell granuloma. Hematoxylin and
gnification and (B) 20× magnification. (C) Same staining predominantly
ell reaction (*) at 40× magnification. (D) Same staining showing a
. POsF, peripheral ossifying fibroma; PGCG, peripheral giant cell granuloma.
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PGCG with osseous formation or metaplasia, instead of
as true hybrid PGCG-POsF lesions. While we agree that
cases of osseous metaplasia in PGCG may be common,
we suggest that the absence of cementum-like elements
alone is not sufficient to reject all such lesions as true
PGCG-POsF hybrid lesions. This is because cases of
POsF lacking distinct cementum-like deposits are not
uncommon. Thus a diagnosis of POsF is based on the
presence of distinct and characteristic stroma, compris-
ing intertwining bundles of collagen admixed with
haphazardly arranged fibroblast-like cells, in association
with bone and/or cementum-like material. Our case
showed a distinct area satisfying the histopathologic fea-
tures of POsF (Figure 3D). The POsF area was unlikely
to represent ‘exuberant callus’ because, although common
in long bones, this is almost never seen at the surface of
jaw bones [11]. Furthermore, there was a noticeable
paucity of red cell extravasation in the stroma of the POsF
portion of the lesion compared with the PGCG portion
(Figure 3C), which showed characteristic exuberance of
red cell extravasation accompanied by hemosiderin de-
posits [11].
Both POsF and PGCG are reactive inflammatory hy-
perplasias arising from the pluripotent cells of the peri-
odontal ligaments [11]. It is therefore conceivable that
both entities represent points on a spectrum of the same
reactive disease process. While the implant treatment in
the vicinity of the lesion may have constituted a persistent
inflammatory trigger or irritant, we suggest the possibility
that the POsF and PGCG arose de novo. Cases of PGCG
associated with dental implant therapies have been re-
ported [19-21]. In most of the cases the implant and res-
toration materials were composed of coronal prosthesis
and were associated with poor oral hygiene [20,21].Conclusion
We report a case of PGCG with a distinct area of exten-
sive osseous formation and stromal area, reminiscent of
that characteristic of POsF. The combined classic histo-
pathologic features of both lesions represented in similar
proportions justify the diagnosis of a combined PGCG-
POsF. The biologic behavior of the combined lesion is
not anticipated to deviate significantly from that of either
of the lesions in their commonly single entity presenta-
tions. We recommend that more cases with histopatho-
logic features similar to our case be reported in the
literature to further elucidate the histogenesis of these
lesions.Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanyingimages. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
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